Evolving Technologies for Tissue Cutting


Journal Article


Jonathon S. Jundt, DDS, MD, Jose M. Marchena, DMD, MD, Issa Hanna, DDS, Jagtar Dhanda, BDS, MFDS RCS(Eng), MBBS, MRCS(Eng), FRCS(OMFS), PhD, Matthew J. Breit, DMD, Andrew P. Perry, DDS


  • Improved technologies for tissue cutting increase surgical precision, reduce or eliminate thermal injury of adjacent tissues, reduce blood loss, decrease operating time, and may improve outcomes.
  • Modern ultrasonic cutting devices reduce the extent of adjacent thermal injury of bone as well as thermal and mechanical injury of surrounding soft tissues compared with traditional rotary instruments or saws.
  • Plasma beams used as cutting devices have been shown to cut with equal or more precision compared with conventional blades and generate reduced levels of thermal injury, inflammation, and scarring compared with conventional electrosurgery.
  • Waterjet dissection allows for precise dissection and ablation of tissues without generating heat and without causing significant structural injury to nerves and vessels.
  • The application of Rapid Ionization Evaporative Mass Spectroscopy of surgical smoke generated by electrocautery is currently undergoing human clinical trials to allow for real-time detection of tumor and assessment of surgical margins.


This literature [author of the literature] was not supported by Apyx Medical, Inc. The opinions contained herein are those of the authors(s) and do not necessarily represent the official position or policies of Apyx Medical, Inc. The author has no financial connection with Apyx Medical, Inc. other than as a purchaser.

Apyx Medical manufactures and owns the Renuvion®/J-Plasma® technology discussed in this article.


  • The Renuvion Precise, Precise Open, and J-Plasma Handpieces are intended to be used with compatible electrosurgical generators for the delivery of radiofrequency energy and/or helium plasma for cutting, coagulation, and ablation of soft tissue during open surgical procedures.
  • Apyx Medical wants to present to you with current scientific discourse.


  • Risk associated with the use of the device may include: Helium embolism into the surgical site due to inadvertent introduction into the venous or arterial blood supply system, unintended burns (deep or superficial), pneumothorax, temporary or permanent nerve injury, ischemia, fibrosis, infection, pain, discomfort, gas buildup resulting in temporary and transient crepitus or pain, bleeding, hematoma, seroma, subcutaneous induration, pigmentation changes, increased healing time, and/or unsatisfactory scarring. There may be additional risks associated with the use of other devices along with Renuvion/J-Plasma and there may be an increased risk for patients who have undergone prior surgical or aesthetic procedures in the treatment area.

As with any procedure, individual results may vary. As with all energy devices there are inherent risks associated with its use, refer to the IFU for further information.